{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:13:02Z","timestamp":1789776782019,"version":"4.0.1"},"reference-count":99,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9,19]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Neutrophils are the first line of defense against invading pathogens. Neutrophils execute and modulate immune responses by generating reactive oxygen species (ROS). Chronic granulomatous disease (CGD) is a primary immune deficiency disorder of phagocytes, caused by inherited mutations in the genes of the nicotinamide adenine dinucleotide phosphate reduced oxidase enzyme. These mutations lead to failure of ROS generation followed by recurrent bacterial and fungal infections, frequently associated with hyperinflammatory manifestations. We report a multicenter cumulative experience in diagnosing and treating patients with CGD. From 1986 to 2021, 2918 patients experiencing frequent infections were referred for neutrophil evaluation. Among them, 110 patients were diagnosed with CGD: 56 of Jewish ancestry, 48 of Arabic ancestry, and 6 of non-Jewish\/non-Arabic ancestry. As opposed to other Western countries, the autosomal recessive (AR) CGD subtypes were predominant in Israel (71\/110 patients). Thirty-nine patients had X-linked CGD, in most patients associated with severe infections (clinical severity score \u22653) and poor outcomes, presenting at a significantly earlier age than AR-CGD subtypes. The full spectrum of infections and hyperinflammatory manifestations is described. Six patients had hypomorphic mutations with significantly milder phenotype, clinical severity score \u22642, and better outcomes. Hematopoietic stem cell transplantation was implemented in 39 of 110 patients (35.5%). Successful engraftment was achieved in 92%, with 82% long-term survival and 71% full clinical recovery. CGD is a complex disorder requiring a multiprofessional team. Early identification of the genetic mutation is essential for prompt diagnosis, suitable management, and prevention.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/blood.2023022590","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T20:55:10Z","timestamp":1719003310000},"page":"1300-1313","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":12,"title":["Genotype-phenotype correlations in chronic granulomatous disease: insights from a large national cohort"],"prefix":"10.1182","volume":"144","author":[{"given":"Baruch","family":"Wolach","sequence":"first","affiliation":[{"name":"1Division of Pediatrics, Pediatric Hematology Clinic, Kfar Saba, Israel"},{"name":"2Hemato-Immunology Laboratory, Meir Medical Center, Kfar Saba, Israel"},{"name":"3Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8708-9647","authenticated-orcid":false,"given":"Ronit","family":"Gavrieli","sequence":"additional","affiliation":[{"name":"1Division of Pediatrics, Pediatric Hematology Clinic, Kfar Saba, Israel"},{"name":"2Hemato-Immunology Laboratory, Meir Medical Center, Kfar Saba, Israel"},{"name":"3Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8662-0707","authenticated-orcid":false,"given":"Ofir","family":"Wolach","sequence":"additional","affiliation":[{"name":"3Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"4Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pazit","family":"Salamon","sequence":"additional","affiliation":[{"name":"5The Herbert Mast Cell Disorders Center, Laboratory of Allergy and Clinical Immunology, Meir Medical Center, Kfar Saba, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"de Boer","sequence":"additional","affiliation":[{"name":"6Sanquin Research, and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"van Leeuwen","sequence":"additional","affiliation":[{"name":"6Sanquin Research, and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Abuzaitoun","sequence":"additional","affiliation":[{"name":"7Ambulatory Pediatrics Clinic, Nablus, Palestinian Authority"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Broides","sequence":"additional","affiliation":[{"name":"8Immunology Clinic, Soroka Medical Center, Beer Sheva, Israel"},{"name":"9Faculty of Health Sciences, Joyce and Irving Goldman Medical School, Ben Gurion University of the Negev, Beer Sheva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giora","family":"Gottesman","sequence":"additional","affiliation":[{"name":"3Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"10Infectious Disease Unit, Division of Pediatrics, Meir Medical Center, Kfar Saba, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galia","family":"Grisaru-Soen","sequence":"additional","affiliation":[{"name":"2Hemato-Immunology Laboratory, Meir Medical Center, Kfar Saba, Israel"},{"name":"11Pediatric Infectious Diseases Unit, Dana-Dwek Children\u2019s Hospital, Sourasky Medical Center, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hagin","sequence":"additional","affiliation":[{"name":"3Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"12Allergy and Clinical Immunology Unit, Department of Medicine, Sourasky Medical Center, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9592-9255","authenticated-orcid":false,"given":"Nufar","family":"Marcus","sequence":"additional","affiliation":[{"name":"3Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"13Allergy and Immunology Unit, Schneider Children's Medical Center, Petah Tikva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menachem","family":"Rottem","sequence":"additional","affiliation":[{"name":"14Allergy Asthma and Immunology Service, Emek Medical Center, Afula, Israel"},{"name":"15Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yechiel","family":"Schlesinger","sequence":"additional","affiliation":[{"name":"16Department of Pediatrics, Shaare Zedek Medical Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tali","family":"Stauber","sequence":"additional","affiliation":[{"name":"3Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"17Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Stepensky","sequence":"additional","affiliation":[{"name":"18Department of Pediatric Hematology-Oncology and Bone Marrow Transplantation, Hadassah Medical Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Dinur-Schejter","sequence":"additional","affiliation":[{"name":"18Department of Pediatric Hematology-Oncology and Bone Marrow Transplantation, Hadassah Medical Center, Jerusalem, Israel"},{"name":"19Allergy and Clinical Immunology Unit and The Bone Marrow Transplantation and Cancer Immunotherapy Department, Hadassah Ein Kerem Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Zeeli","sequence":"additional","affiliation":[{"name":"3Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"20Department of Dermatology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suheir","family":"Hanna","sequence":"additional","affiliation":[{"name":"21Ruth Children's Hospital and Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Etzioni","sequence":"additional","affiliation":[{"name":"21Ruth Children's Hospital and Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirly","family":"Frizinsky","sequence":"additional","affiliation":[{"name":"3Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"22Pediatric Department A and Immunology Service, Jeffrey Modell Foundation Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel"},{"name":"23The Wohl Institute for Translational Medicine, Sheba Medical Center, Tel Hashomer, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raz","family":"Somech","sequence":"additional","affiliation":[{"name":"3Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"22Pediatric Department A and Immunology Service, Jeffrey Modell Foundation Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel"},{"name":"23The Wohl Institute for Translational Medicine, Sheba Medical Center, Tel Hashomer, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5532-0202","authenticated-orcid":false,"given":"Dirk","family":"Roos","sequence":"additional","affiliation":[{"name":"6Sanquin Research, and Landsteiner Laboratory, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8968-4143","authenticated-orcid":false,"given":"Idit","family":"Lachover-Roth","sequence":"additional","affiliation":[{"name":"3Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"24Allergy and Clinical Immunology Unit, Meir Medical Center, Kfar Saba, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7","key":"2024091915210687500_bib1","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1007\/s10875-022-01352-z","article-title":"The 2022 update of IUIS phenotypical classification for human inborn errors of immunity","volume":"42","author":"Bousfiha","year":"2022","journal-title":"J\u00a0Clin Immunol"},{"issue":"3","key":"2024091915210687500_bib2","doi-asserted-by":"crossref","first-page":"e1004651","DOI":"10.1371\/journal.ppat.1004651","article-title":"Neutrophils: between host defence, immune modulation, and tissue injury","volume":"11","author":"Kruger","year":"2015","journal-title":"PLoS Pathog"},{"issue":"5663","key":"2024091915210687500_bib3","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"issue":"1","key":"2024091915210687500_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12964-019-0471-y","article-title":"The regulatory roles of neutrophils in adaptive immunity","volume":"17","author":"Li","year":"2019","journal-title":"Cell Commun Signal"},{"key":"2024091915210687500_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-0716-0154-9_2","article-title":"Neutrophil defects and diagnosis disorders of neutrophil function: an overview","volume":"2087","author":"Dinauer","year":"2020","journal-title":"Methods Mol Biol"},{"issue":"3","key":"2024091915210687500_bib6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s10875-011-9633-4","article-title":"Lessons learned from phagocytic function studies in a large cohort of patients with recurrent infections","volume":"32","author":"Wolach","year":"2012","journal-title":"J\u00a0Clin Immunol"},{"issue":"1","key":"2024091915210687500_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol Rev"},{"key":"2024091915210687500_bib8","first-page":"35","volume-title":"Genetics, Biology and Clinical Management","author":"Kuijpers","year":"2017"},{"issue":"1","key":"2024091915210687500_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/bmb\/ldw009","article-title":"Chronic granulomatous disease","volume":"118","author":"Roos","year":"2016","journal-title":"Br Med Bull"},{"key":"2024091915210687500_bib10","doi-asserted-by":"crossref","first-page":"102587","DOI":"10.1016\/j.bcmd.2021.102587","article-title":"Hematologically important mutations: X-linked chronic granulomatous disease (fourth update)","volume":"90","author":"Roos","year":"2021","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"2024091915210687500_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bcmd.2010.01.009","article-title":"Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update)","volume":"44","author":"Roos","year":"2010","journal-title":"Blood Cells Mol Dis"},{"key":"2024091915210687500_bib12","first-page":"204","volume-title":"Genetics, Biology and Clinical Management","author":"Battersby","year":"2017"},{"key":"2024091915210687500_bib13","first-page":"92","volume-title":"Genetics, Biology and Clinical Management","author":"Segal","year":"2017"},{"issue":"suppl 1","key":"2024091915210687500_bib14","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1093\/jpids\/piy014","article-title":"Noninfectious manifestations and complications of chronic granulomatous disease","volume":"7","author":"Henrickson","year":"2018","journal-title":"J\u00a0Pediatric Infect Dis Soc"},{"key":"2024091915210687500_bib15","first-page":"164","volume-title":"Genetics, Biology and Clinical Management","author":"Marciano","year":"2017"},{"key":"2024091915210687500_bib16","doi-asserted-by":"crossref","first-page":"252460","DOI":"10.1155\/2012\/252460","article-title":"Current concepts of hyperinflammation in chronic granulomatous disease","volume":"2012","author":"Rieber","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"suppl 1","key":"2024091915210687500_bib17","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1093\/jpids\/piy015","article-title":"Allogeneic hematopoietic cell transplantation for chronic granulomatous disease: controversies and state of the art","volume":"7","author":"Connelly","year":"2018","journal-title":"J\u00a0Pediatric Infect Dis Soc"},{"key":"2024091915210687500_bib18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3389\/fped.2020.00327","article-title":"Cellular therapies in chronic granulomatous disease","volume":"8","author":"G\u00fcng\u00f6r","year":"2020","journal-title":"Front Pediatr"},{"issue":"4","key":"2024091915210687500_bib19","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s10875-019-00635-2","article-title":"Role of allogeneic hematopoietic stem cell transplant for chronic granulomatous disease (CGD): a report of the United States Immunodeficiency Network","volume":"39","author":"Yonkof","year":"2019","journal-title":"J\u00a0Clin Immunol"},{"issue":"10","key":"2024091915210687500_bib20","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood.2020005590","article-title":"Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults","volume":"136","author":"Chiesa","year":"2020","journal-title":"Blood"},{"key":"2024091915210687500_bib21","first-page":"351","volume-title":"Genetics, Biology and Clinical Management","author":"Siler","year":"2017"},{"issue":"suppl 1","key":"2024091915210687500_bib22","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1093\/jpids\/piy011","article-title":"Future of care for patients with chronic granulomatous disease: gene therapy and targeted molecular medicine","volume":"7","author":"Keller","year":"2018","journal-title":"J\u00a0Pediatric Infect Dis Soc"},{"issue":"1","key":"2024091915210687500_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ajh.24573","article-title":"Chronic granulomatous disease: clinical, functional, molecular, and genetic studies: the Israeli experience with 84 patients","volume":"92","author":"Wolach","year":"2017","journal-title":"Am J Hematol"},{"issue":"1","key":"2024091915210687500_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clim.2008.06.012","article-title":"Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients","volume":"129","author":"Wolach","year":"2008","journal-title":"Clin Immunol"},{"key":"2024091915210687500_bib25","first-page":"77","article-title":"Isolation of mononuclear cells and granulocytes from human blood: isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g","volume":"97","author":"B\u00f6yum","year":"1968","journal-title":"Scand J Clin Lab Invest Suppl"},{"issue":"2","key":"2024091915210687500_bib26","first-page":"316","article-title":"Quantitation of maximal bactericidal capability in human neutrophils","volume":"88","author":"Clawson","year":"1976","journal-title":"J\u00a0Lab Clin Med"},{"issue":"8","key":"2024091915210687500_bib27","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1172\/JCI59832","article-title":"Evidence for bistable bacteria-neutrophil interaction and its clinical implications","volume":"122","author":"Malka","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"2024091915210687500_bib28","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/jlb.66.6.1014","article-title":"P40phox associates with the neutrophil Triton X-100-insoluble cytoskeletal fraction and PMA-activated membrane skeleton: a comparative study with P67phox and P47phox","volume":"66","author":"El Benna","year":"1999","journal-title":"J\u00a0Leukoc Biol"},{"issue":"11","key":"2024091915210687500_bib29","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.4049\/jimmunol.137.11.3584","article-title":"Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors","volume":"137","author":"Weisbart","year":"1986","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"2024091915210687500_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0022-1759(94)00247-T","article-title":"Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes","volume":"178","author":"Vowells","year":"1995","journal-title":"J\u00a0Immunol Methods"},{"issue":"6","key":"2024091915210687500_bib31","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1182\/blood.V73.6.1686.1686","article-title":"Characterization of two monoclonal antibodies against cytochrome b558 of human neutrophils","volume":"73","author":"Verhoeven","year":"1989","journal-title":"Blood"},{"issue":"25","key":"2024091915210687500_bib32","doi-asserted-by":"crossref","first-page":"18593","DOI":"10.1016\/S0021-9258(17)46669-5","article-title":"Inhibition of neutrophil NADPH oxidase assembly by a myristoylated pseudosubstrate of protein kinase C","volume":"268","author":"Verhoeven","year":"1993","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"2024091915210687500_bib33","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1182\/blood.V87.5.1663.1663","article-title":"Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease","volume":"87","author":"Roos","year":"1996","journal-title":"Blood"},{"issue":"9","key":"2024091915210687500_bib34","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sj.ejhg.5200523","article-title":"A\u00a0new exon created by intronic insertion of a rearranged LINE-1 element as the cause of chronic granulomatous disease","volume":"8","author":"Meischl","year":"2000","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"2024091915210687500_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1182\/blood-2004-02-0675","article-title":"Unusual late presentation of X-linked chronic granulomatous disease in an adult female with a somatic mosaic for a novel mutation in CYBB","volume":"105","author":"Wolach","year":"2005","journal-title":"Blood"},{"issue":"27","key":"2024091915210687500_bib36","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1056\/NEJMoa1007097","article-title":"Residual NADPH oxidase and survival in chronic granulomatous disease","volume":"363","author":"Kuhns","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"2024091915210687500_bib37","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s10875-020-00820-8","article-title":"Novel NCF2 mutation causing chronic granulomatous disease","volume":"40","author":"Roth","year":"2020","journal-title":"J\u00a0Clin Immunol"},{"issue":"2","key":"2024091915210687500_bib38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10875-018-0475-1","article-title":"Analysis of chronic granulomatous disease in the Kavkazi population in Israel reveals phenotypic heterogeneity in patients with the same NCF1 mutation (c.579G&gt;A)","volume":"38","author":"Wolach","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"issue":"2","key":"2024091915210687500_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.14785\/lymphosign-2018-0004","article-title":"Chronic granulomatous disease due to different mutations in patients from the same consanguineous extended family","volume":"5","author":"Broides","year":"2018","journal-title":"LymphoSign J"},{"issue":"2","key":"2024091915210687500_bib40","first-page":"15","article-title":"Aspergillosis in chronic granulomatous disease","volume":"2","author":"King","year":"2016","journal-title":"J\u00a0Fungi (Basel)"},{"issue":"3","key":"2024091915210687500_bib41","first-page":"242","article-title":"Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications","volume":"16","author":"Sherif","year":"2010","journal-title":"Curr Opin Pulm Med"},{"issue":"9","key":"2024091915210687500_bib42","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/sj.bmt.1702651","article-title":"Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation","volume":"26","author":"Bielorai","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2024091915210687500_bib43","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/pai.12884","article-title":"Burkholderia gladioli-associated facial pustulosis as a first sign of chronic granulomatous disease in a child - case report and review","volume":"29","author":"Marom","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"issue":"7","key":"2024091915210687500_bib44","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1365-2230.2011.04101.x","article-title":"Chronic granulomatous disease of childhood: an unusual cause of recurrent uncommon infections in a 61-year-old man","volume":"36","author":"Isman-Nelkenbaum","year":"2011","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"2024091915210687500_bib45","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0022-3476(99)70299-4","article-title":"Chorioretinal lesions in patients and carriers of chronic granulomatous disease","volume":"134","author":"Goldblatt","year":"1999","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"2024091915210687500_bib46","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jaci.2008.07.050","article-title":"Chronic granulomatous disease as a risk factor for autoimmune disease","volume":"122","author":"De Ravin","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"2024091915210687500_bib47","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/0959-8049(95)00627-3","article-title":"Increased risk of malignancy for patients with chronic granulomatous disease and its possible link to the pathogenesis of cancer","volume":"32a","author":"Weel","year":"1996","journal-title":"Eur J Cancer"},{"issue":"2","key":"2024091915210687500_bib48","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jaci.2010.10.049","article-title":"Hodgkin lymphoma in 2 children with chronic granulomatous disease","volume":"127","author":"Lugo Reyes","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"12","key":"2024091915210687500_bib49","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/MPH.0b013e3181b84751","article-title":"Glioblastoma multiforme in a patient with chronic granulomatous disease treated with subtotal resection, radiation, and thalidomide: case report of a long-term survivor","volume":"31","author":"Aguilera","year":"2009","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"1","key":"2024091915210687500_bib50","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ajh.20424","article-title":"Acute lymphoblastic leukemia in a patient with chronic granulomatous disease and a novel mutation in CYBB: first report","volume":"80","author":"Wolach","year":"2005","journal-title":"Am J Hematol"},{"issue":"3","key":"2024091915210687500_bib51","first-page":"22","article-title":"Galactomannan and 1,3-\u03b2-d-glucan testing for the diagnosis of invasive Aspergillosis","volume":"2","author":"Lamoth","year":"2016","journal-title":"J\u00a0Fungi (Basel)"},{"issue":"10","key":"2024091915210687500_bib52","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1128\/JCM.38.10.3900-3901.2000","article-title":"Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis","volume":"38","author":"Verweij","year":"2000","journal-title":"J\u00a0Clin Microbiol"},{"key":"2024091915210687500_bib53","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/PHMT.S254253","article-title":"Geographic variability and pathogen-specific considerations in the diagnosis and management of chronic granulomatous disease","volume":"11","author":"Prince","year":"2020","journal-title":"Pediatric Health Med Ther"},{"key":"2024091915210687500_bib54","first-page":"125","volume-title":"Endemic Infections in Chronic Granulomatous Disease","author":"Lee","year":"2017"},{"issue":"1","key":"2024091915210687500_bib55","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jaci.2015.11.041","article-title":"Mycobacterial disease in patients with chronic granulomatous disease: a retrospective analysis of 71 cases","volume":"138","author":"Conti","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"2024091915210687500_bib56","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.arcped.2016.04.003","article-title":"[BCGitis\/BCGosis in children: diagnosis, classification and exploration]","volume":"23","author":"Kourime","year":"2016","journal-title":"Arch Pediatr"},{"issue":"3","key":"2024091915210687500_bib57","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s10875-018-0486-y","article-title":"A\u00a0cohort of 169 chronic granulomatous disease patients exposed to BCG vaccination: a retrospective study from a single center in Shanghai, China (2004-2017)","volume":"38","author":"Zhou","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"issue":"2","key":"2024091915210687500_bib58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10875-019-00607-6","article-title":"Health-related quality of life and emotional health in X-linked carriers of chronic granulomatous disease in the United Kingdom","volume":"39","author":"Battersby","year":"2019","journal-title":"J\u00a0Clin Immunol"},{"issue":"1","key":"2024091915210687500_bib59","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/archdischild-2011-300780","article-title":"Emotional and behavioural difficulties in chronic granulomatous disease","volume":"97","author":"Cole","year":"2012","journal-title":"Arch Dis Child"},{"issue":"3","key":"2024091915210687500_bib60","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0925-4439(01)00110-7","article-title":"Molecular and functional characterization of a new X-linked chronic granulomatous disease variant (X91+) case with a double missense mutation in the cytosolic gp91phox C-terminal tail","volume":"1586","author":"Stasia","year":"2002","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"2024091915210687500_bib61","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s10875-011-9537-3","article-title":"Two X-linked chronic granulomatous disease patients with unusual NADPH oxidase properties","volume":"31","author":"Wolach","year":"2011","journal-title":"J\u00a0Clin Immunol"},{"issue":"6","key":"2024091915210687500_bib62","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/INF.0b013e318194cf09","article-title":"Family clusters of variant X-linked chronic granulomatous disease","volume":"28","author":"Bender","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"2024091915210687500_bib63","first-page":"1000231","article-title":"Two CGD families with a hypomorphic mutation in the activation domain of p67(phox)","volume":"5","author":"Roos","year":"2014","journal-title":"J\u00a0Clin Cell Immunol"},{"key":"2024091915210687500_bib64","volume-title":"Guidance for the National Healthcare Disparities Report","author":"Ricketts","year":"2002"},{"key":"2024091915210687500_bib65","first-page":"179","volume-title":"Studies in Israeli Ethnicity: After the Ingathering","author":"Goldberg","year":"1985"},{"key":"2024091915210687500_bib66","first-page":"280","volume-title":"Challenging the Modern Synthesis: Adaptation, Development and Inheritance","author":"Uller","year":"2017"},{"key":"2024091915210687500_bib67","first-page":"63","volume-title":"Genetic Disorders Among Arab Populations","author":"Khlat","year":"1997"},{"key":"2024091915210687500_bib68","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.2011.06260.x","article-title":"Primary immunodeficiencies in highly consanguineous North African populations","volume":"1238","author":"Barbouche","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"2024091915210687500_bib69","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ng0295-99","article-title":"Jewish diseases and origins","volume":"9","author":"Motulsky","year":"1995","journal-title":"Nat Genet"},{"issue":"3","key":"2024091915210687500_bib70","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/jmg.26.3.179","article-title":"Medical genetics in Israel","volume":"26","author":"Goodman","year":"1989","journal-title":"J\u00a0Med Genet"},{"issue":"7573","key":"2024091915210687500_bib71","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/bmj.38982.704931.AE","article-title":"Genetic disorders in the Arab world","volume":"333","author":"Al-Gazali","year":"2006","journal-title":"BMJ"},{"issue":"2","key":"2024091915210687500_bib72","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.gene.2016.07.007","article-title":"The Arab genome: health and wealth","volume":"592","author":"Zayed","year":"2016","journal-title":"Gene"},{"key":"2024091915210687500_bib73","doi-asserted-by":"crossref","first-page":"639226","DOI":"10.3389\/fimmu.2021.639226","article-title":"Second report of chronic granulomatous disease in Jordan: clinical and genetic description of 31 patients from 21 different families, including families from Lybia and Iraq","volume":"12","author":"Bakri","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"2024091915210687500_bib74","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jaci.2013.05.039","article-title":"Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients","volume":"132","author":"K\u00f6ker","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"2024091915210687500_bib75","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s10875-011-9567-x","article-title":"Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease","volume":"31","author":"Fattahi","year":"2011","journal-title":"J\u00a0Clin Immunol"},{"issue":"8","key":"2024091915210687500_bib76","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s10875-023-01541-4","article-title":"Chronic granulomatous disease: a cohort of 173 patients-10-years single center experience from Egypt","volume":"43","author":"Abd Elaziz","year":"2023","journal-title":"J\u00a0Clin Immunol"},{"issue":"4","key":"2024091915210687500_bib77","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.bcmd.2015.07.014","article-title":"A\u00a0founder effect for p47(phox)Trp193Ter chronic granulomatous disease in Kavkazi Jews","volume":"55","author":"de Boer","year":"2015","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"2024091915210687500_bib78","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/jmedgenet-2017-105022","article-title":"A\u00a0false-carrier state for the c.579G&gt;A mutation in the NCF1 gene in Ashkenazi Jews","volume":"55","author":"De Boer","year":"2018","journal-title":"J\u00a0Med Genet"},{"key":"2024091915210687500_bib79","first-page":"1","volume-title":"Gene Reviews [online]","author":"Leiding","year":"2016"},{"key":"2024091915210687500_bib80","first-page":"231","volume-title":"Chronic Granulomatous Disease. Genetics, Biology and Clinical Management","author":"Roos","year":"2017"},{"issue":"2","key":"2024091915210687500_bib81","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.iac.2008.01.005","article-title":"The hyper-IgE syndromes","volume":"28","author":"Freeman","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"issue":"suppl 1","key":"2024091915210687500_bib82","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1093\/jpids\/piy007","article-title":"Considerations in the diagnosis of chronic granulomatous disease","volume":"7","author":"Yu","year":"2018","journal-title":"J\u00a0Pediatric Infect Dis Soc"},{"key":"2024091915210687500_bib83","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1471-2431-14-156","article-title":"Chronic granulomatous disease mimicking early-onset Crohn's disease with cutaneous manifestations","volume":"14","author":"Barbato","year":"2014","journal-title":"BMC Pediatr"},{"issue":"3","key":"2024091915210687500_bib84","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.cgh.2015.10.030","article-title":"Gastrointestinal features of chronic granulomatous disease found during endoscopy","volume":"14","author":"Khangura","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"2024091915210687500_bib85","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood.V100.3.1026","article-title":"Deletion of leucine 61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections","volume":"100","author":"van Bruggen","year":"2002","journal-title":"Blood"},{"issue":"5","key":"2024091915210687500_bib86","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1203\/01.PDR.0000120680.47846.47","article-title":"Diurnal fluctuation of leukocyte G6PD activity: a possible explanation for the normal neutrophil bactericidal activity and the low incidence of pyogenic infections in patients with severe G6PD deficiency in Israel","volume":"55","author":"Wolach","year":"2004","journal-title":"Pediatr Res"},{"issue":"9","key":"2024091915210687500_bib87","first-page":"2955","article-title":"Molecular basis and enzymatic properties of glucose 6-phosphate dehydrogenase volendam, leading to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections","volume":"94","author":"Roos","year":"1999","journal-title":"Blood"},{"issue":"3","key":"2024091915210687500_bib88","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/infdis\/162.3.723","article-title":"Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease","volume":"162","author":"Margolis","year":"1990","journal-title":"J\u00a0Infect Dis"},{"issue":"24","key":"2024091915210687500_bib89","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa021931","article-title":"Itraconazole to prevent fungal infections in chronic granulomatous disease","volume":"348","author":"Gallin","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"2024091915210687500_bib90","doi-asserted-by":"crossref","first-page":"e0263370","DOI":"10.1371\/journal.pone.0263370","article-title":"In\u00a0vivo interferon-gamma induced changes in gene expression dramatically alter neutrophil phenotype","volume":"17","author":"Ambruso","year":"2022","journal-title":"PLoS One"},{"issue":"5","key":"2024091915210687500_bib91","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/422993","article-title":"Long-term interferon-gamma therapy for patients with chronic granulomatous disease","volume":"39","author":"Marciano","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2024091915210687500_bib92","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2249.1992.tb03062.x","article-title":"Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti-microbial proteins","volume":"88","author":"M\u00fchlebach","year":"1992","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"2024091915210687500_bib93","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM199102213240801","article-title":"A\u00a0controlled trial of interferon gamma to prevent infection in chronic granulomatous disease","volume":"324","author":"International Chronic Granulomatous Disease Cooperative Study Group","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"2024091915210687500_bib94","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clim.2007.09.008","article-title":"Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study","volume":"126","author":"Martire","year":"2008","journal-title":"Clin Immunol"},{"issue":"5","key":"2024091915210687500_bib95","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/cid\/cir896","article-title":"Corticosteroid therapy for liver abscess in chronic granulomatous disease","volume":"54","author":"Leiding","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2024091915210687500_bib96","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/cid\/cix1012","article-title":"The changing paradigm of management of liver abscesses in chronic granulomatous disease","volume":"66","author":"Straughan","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2024091915210687500_bib97","doi-asserted-by":"crossref","first-page":"888392","DOI":"10.3389\/fimmu.2022.888392","article-title":"Systematic review of safety and efficacy of IL-1-targeted biologics in treating immune-mediated disorders","volume":"13","author":"Arnold","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"2024091915210687500_bib98","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s10875-017-0422-6","article-title":"Allogeneic reduced-intensity hematopoietic stem cell transplantation for chronic granulomatous disease: a single-center prospective trial","volume":"37","author":"Parta","year":"2017","journal-title":"J\u00a0Clin Immunol"},{"issue":"2","key":"2024091915210687500_bib99","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41591-019-0735-5","article-title":"Lentiviral gene therapy for X-linked chronic granulomatous disease","volume":"26","author":"Kohn","year":"2020","journal-title":"Nat Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/144\/12\/1300\/2242647\/blood_bld-2023-022590-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/144\/12\/1300\/2242647\/blood_bld-2023-022590-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T16:36:32Z","timestamp":1726763792000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/144\/12\/1300\/516664\/Genotype-phenotype-correlations-in-chronic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":99,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,9,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023022590","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]}}}